Abhishek K. Verma

A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies

Yushun Wan, Wanbo Tai, Xiujuan Zhang, 2024, JCI insight.

Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection

Grant M. Hawkins, D. Meyerholz, C. Wohlford-Lenane, 2024, Journal of virology.